Aichtal, Germany

Svenja Reimer

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Polymedics Innovations Gmbh. Active years: 2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Svenja Reimer: Innovator in Medical Wound Treatment

Introduction

Svenja Reimer is a notable inventor based in Aichtal, Germany. She has made significant contributions to the field of medical technology, particularly in the area of wound treatment. Her innovative approach combines advanced materials with practical applications in healthcare.

Latest Patents

Svenja Reimer holds a patent for a two-dimensional material designed for medical wound area treatment. This invention involves a non-woven fabric made from resorbable polymer filaments and collagen particles, which have a particle size greater than 80 μm. This unique composition is intended to enhance the healing process in medical applications.

Career Highlights

Svenja is currently associated with Polymedics Innovations GmbH, where she continues to develop cutting-edge solutions for medical challenges. Her work focuses on integrating innovative materials into practical healthcare applications, showcasing her commitment to improving patient outcomes.

Collaborations

Svenja collaborates with talented individuals in her field, including Heinrich Planck and Christian Planck. These partnerships enhance her research and development efforts, allowing for a more comprehensive approach to innovation in medical technology.

Conclusion

Svenja Reimer's contributions to medical wound treatment through her patented innovations exemplify her dedication to advancing healthcare technology. Her work not only reflects her expertise but also her commitment to improving the quality of life for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…